Tyra biosciences to participate in cowen 42nd annual healthcare conference

Carlsbad, calif., feb. 22, 2022 /prnewswire/ -- tyra biosciences, inc. (nasdaq: tyra), a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer, today announced that tyra management will be participating in a corporate panel discussion at the cowen 42nd annual healthcare conference, taking place virtually march 7-9, 2022.
TYRA Ratings Summary
TYRA Quant Ranking